Don't Confuse the New Quinolone Baxdela for Other "Floxacin" Antibiotics

November 2017

Baxdela (baks-DEH-lah, delafloxacin) will be the latest "quinolone" antibiotic.

It'll be saved as a last resort for certain skin infections...such as those caused by methicillin-resistant Staph aureus (MRSA).

Expect most patients on Baxdela to get 450 mg by mouth...or 300 mg IV...every 12 hours for 5 to 14 days. Therapy length will depend on the severity and type of skin infection being treated.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Practice Don't Let Patients Get Meds Past Their Expiration or Beyond-Use Dates
Critical Care Having the Right Meds On Hand is Vital for Rapid Sequence Intubation
High-Alert Meds Renew Your Efforts to Prevent Common Med Errors
New Drugs Don't Confuse the New Quinolone Baxdela for Other "Floxacin" Antibiotics
Blood Products Jehovah's Witness Patients May Not Accept Blood-Related Meds
Gout Duzallo Combines Lesinurad and Allopurinol in One Tab for Gout
Med Administration Don't Be Surprised to See Inhaled Steroid Orders With Instructions to "Swallow"
Diuretics CaroSpir Has Different Dosing Than Spironolactone Tablets
Interactions Expect Oral Meds to Be Given 3 Hours Before or After Potassium Binders
Antibiotics Prep Antibiotics for Inhalation With Preservative-Free Versions

Don't Confuse the New Quinolone Baxdela for Other "Floxacin" Antibiotics

Practical advice for a better career, with unlimited access to CE

Table of Contents